Page 4 - Optune Lua News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NovoCure (NASDAQ:NVCR – Get Free Report) and Minerva Surgical (NASDAQ:UTRS – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends. Institutional and Insider Ownership 84.6% of NovoCure shares […]

Wedbush reissued their neutral rating on shares of NovoCure (NASDAQ:NVCR – Free Report) in a report published on Wednesday, RTT News reports. The firm currently has a $21.00 price target on the medical equipment provider’s stock. Wedbush also issued estimates for NovoCure’s Q4 2025 earnings at ($0.36) EPS, FY2026 earnings at ($1.45) EPS and FY2027 […]

-- Health care stocks were higher pre-bell Wednesday as the Health Care Select Sector SPDR Fund was up 0.6% and the iShares Biotechnology ETF was recently advancing by 0.8%. NovoCure was up...

NovoCure Limited (NASDAQ:NVCR – Get Free Report) EVP Frank X. Leonard sold 2,078 shares of the company’s stock in a transaction on Wednesday, February 28th. The shares were sold at an average price of $16.14, for a total value of $33,538.92. Following the transaction, the executive vice president now directly owns 162,617 shares in the […]